[1] CENTERS FOR DISEASE CONTROL AND PREVENTION. Global HIV and TB. [EB/OL]. [2023-01-16]. https://www.cdc.gov/globalhivtb/images/DGHT-HIV-Factsheet.pdf
[2] SEPKOWITZ KA.Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome[J]. Clin Infect Dis, 2002, 34(8): 1098-1107.
[3] KAPLAN JE, HANSON D, DOWRKING MS.Epidemiology of human immunodeficiency virus associated opportunistuc infection in the United States in the era of highly active antiretroviral therapy[J]. Clin Infect Dis, 2000, 30(Suppl 1): S5-S14.
[4] 宋文艳,李宏军. 艾滋病合并卡氏肺囊虫肺炎的临床影像研究[J].医学影像学杂志,2010, 20(5):652-655.
[5] 李丹, 卢洪洲. 肺孢子菌的新命名[J]. 微生物与感染. 2008, 3(1):30-31.
[6] MATULIONYTE R, AMBROZAITIS A, PAULAUSKIENE R, et al.[Pneumocystis jirovecii pneumonia: an old disease with a new name[J]. Medicina, 2006, 42(8):643-648
[7] THOMAS CF JR, LIMPER AH.Pneumocystis Pneumonia[J]. N Engl J Med, 2004, 350(24):2487-2498.
[8] DE BOER MG, DE FIJTER JW, Kroon FP.Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review[J]. Med Mycol, 2021, 49(7):673-680.
[9] MONTES-CANO MA, CHABÉ M,FONTILLON-ALBERDI M, et al. 2009. Vertical transmission of Pneumocystis jirovecii in humans[J]. Emerg Infect Dis, 2009, 15(1):125-127.
[10] CHABÉ M, ALIOUAT-DENIS CM, DELHAES L, et al.Pneumocystis: from a doubtful unique entity to a group of highly diversified fungal species[J]. FEMS Yeast Res, 2021, 11(1):2-17.
[11] PETERSON JC, CUSHION MT.Pneumocystis: not just pneumonia[J]. Curr Opin Microbiol, 2005, 8:393-398.
[12] LE GAL S, DAMIANI C, ROUILLÉ A, et al.A cluster of Pneumocystis infections among renal transplant recipients: molecular evidence of colonized patients as potential infectious sources of Pneumocystis jirovecii[J]. Clin Infect Dis, 2012, 54(7) :e62-71.
[13] ALANIO A, BRETAGNE S.Pneumocystis jirovecii Detection in Asymptomatic Patients: What Does its Natural History Tell us[J] F1000 Faculty Rev, 2007, 23(6):739.
[14] GAJDUSEK DC.Pneumocystis carinii; etiologic agent of interstitial plasma cell pneumonia of premature and young infants[J]. Pediatrics, 1957, 19(4 Pt 1):543-565.
[15] HAY JW, OSMOND DH, JACOBSON MA.Projecting the medical costs of AIDS and ARC in the United States[J]. J Acquir Immune Defic Syndr, 1988, 1(5):466-485.
[16] BROWN GD, DENNING DW, GOW NA, et al.Hidden killers: human fungal infections[J]. Sci Transl Med, 2012, 19(4):165rv13.
[17] MASCHMEYER G, HELWEG-LARSEN J, PAGANO L, et al.ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients[J]. J Antimicrob Chemother, 2016, 71(9):2405-2413.
[18] MCKINNELL JA, CANNELLA AP, KUNZ DF, et al.Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons[J]. Transpl Infect Dis, 2012, 14(5):510-518.
[19] BIENVENU AL, TRAORE K, PLEKHANOVA I, et al.Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients[J]. Int J Infect Dis, 2016, 46: 11-17.
[20] GARCIA GF, MOURA AS, FERREIRA CS, et al.Clinical and radiographic features of HIV-related pulmonary tuberculosis according to the level of immunosuppression[J]. Rev Soc Bras Med Trop, 2007, 40(6):622-626.
[21] CALDERON EJ, GUTIERREZ-RIVERO S, DURAND-JOLY I, et al.Pneumocystis infection in humans: diagnosis and treatment[J]. Expert Rev Anti Infect Ther, 2010, 8(6):683-701.
[22] DURAND-JOLY I, CHABE M, SOULA F, et al.Molecular diagnosis of Pneumocystis pneumonia[J]. FEMS Immunol Med Microbiol, 2005, 45(3):405-410.
[23] BOTTEREL F, CABARET O, FOULET F, et al.2012. Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients[J]. J Clin Microbiol, 2012, 50(2):227-231.
[24] FILLAUX J, BERRY A.2013. Real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia[J]. Methods Mol Biol, 2013, 943:159-170.
[25] DALPKE AH, HOFKO M, ZIMMERMANN S.Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii on the fully automated BD MAX platform[J]. J Clin Microbiol, 2013, 51(7):2337-2344.
[26] GAGO S, ESTEBAN C, VALERO C, et al.A multiplex real-time PCR assay for identification of Pneumocystis jirovecii, Histoplasma capsulatum, and Cryptococcus neoformans/Cryptococcus gattii in samples from AIDS patients with opportunistic pneumonia[J]. J Clin Microbiol, 2014, 52(4):1168-1176.
[27] TASAKA S, HASEGAWA N, KOBAYASHI S, et al.Serum indicators for the diagnosis of pneumocystis pneumonia[J]. Chest, 2007, 131(4):1173-1180.
[28] AVIRAM G. BOISELLE PM.Imaging features of bacterial respiratory infections in AIDS[J]. Curr 0pin Pul/n Mad, 2004, 10(3):183-188.
[29] 刘德纯,李宏军.艾滋病与艾滋病毒感染者48例临床影像与病理分析[J/CD].新发传染病电子杂志,2019,4(3):152-155,159.
[30] HARDAK E, BROOK O, YIGLA M.Radiological features of Pneumocystis jirovecii Pneumonia in immunocompromised patients with AND without AIDS[J]. Lung, 2010, 188(2): 159-163.
[31] BOISELLE PM, CRANS CA JR, KAPLAN MA.The changing face of Pneumocystis carinii pneumonia in AIDS patients[J]. AJR Am J Roentgenol, 1999, 172(5):1301-1309.
[32] 赵大伟, 张可, 马大庆, 等. 艾滋病合并卡氏肺孢子菌肺炎的影像学表现[J]. 中华放射学杂志, 2002, 36(4)(4):63-65.
[33] 陆普选, 邓莹莹, 刘水腾, 等. 艾滋病合并肺孢子菌肺炎的影像学表现特征及分型[J]. 放射学实践, 2009, 24(9):948-951.
[34] FUJII T, NAKAMURA T, IWAMOTO A.Pneumocystis pneumonia in patients with HIV infection: clinical manifestations, laboratory findings, and radiological features[J]. J Infect Chemother, 2007, 13(1):1-7.
[35] 丘金铭, 吴仁华. 肺孢子菌肺炎的影像学表现[J/CD]. 新发传染病电子杂志, 2019, 4(4):235-239. |